✨ Free AI Report
Allergan plc: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Allergan plc
Company Research

Allergan plc: Business Overview, Financials & Competitive Analysis

Allergan plc scores 6/10 on the AskCyborg Cyborg Score (Solid). Established pharmaceutical diversification provides resilience, but dependent on pipeline innovation and market access execution. Allergan demonstrates stability as a diversified pharmaceutical manufacturer with established therapeutic areas and significant scale. However, recent search results show limited concrete 2025-2026 financial data, and the pharmaceutical sector faces ongoing pricing pressures and competitive dynamics.

What is Allergan plc's industry? Allergan plc (allergan.com) operates in Generic Drugs. AskCyborg classifies Allergan plc under Generic Drugs in its company registry.

Allergan is a developer and manufacturer of a portfolio of generic medicines focused on various therapeutic categories, including dermatology and aesthetics, CNS, eye care, women's health, urology, GI and cystic fibro...

6/ 10Solid

Cyborg Score thesis

Established pharmaceutical diversification provides resilience, but dependent on pipeline innovation and market access...

Read the full analyst-debate transcript →
Industry Generic Drugs
4 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 14, 2026
AI-Verified Research
30+ Page Report

Get the Latest Allergan plc Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Allergan plc

AskCyborg analysts argue the bull and bear cases for Allergan plc across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Allergan plc OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Allergan plc Overview

Pro stress-test →

Allergan is a developer and manufacturer of a portfolio of generic medicines focused on various therapeutic categories, including dermatology and aesthetics, CNS, eye care, women's health, urology, GI and cystic fibrosis, cardiovascular, and infectious disease. As a publicly traded pharmaceutical company on the NYSE, Allergan serves a diverse global patient base across multiple treatment areas.

Strategic Profile

Pro stress-test →

As of March 31, 2026, Allergan employs 10,043 people. The company operates across broad therapeutic segments with established commercial operations in key markets. Allergan's diversified portfolio spans both specialty and generic pharmaceutical offerings.

Competitive Landscape

Pro stress-test →

Allergan competes within the diversified pharmaceutical landscape against both branded and generic manufacturers including Teva, Mylan, Sun Pharmaceutical, and branded leaders like Pfizer, Johnson & Johnson, and AbbVie, particularly in aesthetics, CNS, and ophthalmology segments where brand recognition and market access are critical.

Industry Context

Allergan plc operates in Generic Drugs.

Key facts

Founded: 1950 · Headquarters: Dublin, Ireland · Employees: 10,043 · Revenue: $5.8B (2013) · Market cap: N/A

What the analysts stress-tested

The top findings that survived the multi-agent debate for Allergan plc.

  • Diversified therapeutic portfolio reduces dependency on any single product or market segment
  • Global presence across dermatology, CNS, ophthalmology, and specialty care offers multiple growth vectors
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • As of March 31, 2026, company maintains workforce of 10,043 employees
  • No major merger, acquisition, or partnership announcements found in recent search results
  • +1 moreTrack every material event for Allergan plc as it happens. Explore monitoring →
Get alerted when Allergan plc has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

BotoxLeading aesthetic injection treatment→Generic Pharmaceuticals PortfolioGlobal generic and specialty pharma→Generic PharmaceuticalsDiversified generic medicines→Specialty PharmaceuticalsDiversified specialty and generic pharma→

Compare Allergan plc with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Allergan plc operates in Generic Drugs. See how the rest of the sector scores on the Cyborg framework.

Browse Generic Drugs research →
NEW · MCP server

Ask your AI assistant about Allergan plc

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Allergan plc and its top competitor on Cyborg Score”
“What did Allergan plc do this quarter?”
“Is Allergan plc a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Allergan plc do?+
Allergan is a developer and manufacturer of a portfolio of generic medicines focused on various therapeutic categories, including dermatology and aesthetics, CNS, eye care, women's health, urology, GI and cystic fibro...
What is Allergan plc's Cyborg Score?+
Allergan plc has a Cyborg Score of 6/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Allergan plc's main competitors?+
Named competitors include Botox, Generic Pharmaceuticals Portfolio, Generic Pharmaceuticals, Specialty Pharmaceuticals. The full competitive landscape is in the AskCyborg report.
How can I get the full Allergan plc research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Allergan plc research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Allergan plc over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.